SPI Medical Imaging: Lessons from a Unicorn: An Assessment of HeartFlow’s Ambition and Execution

Publication Date: 22/07/2021

Written by

Alan Stoddart headshot
Alan Stoddart

HeartFlow has continued to build on its success, recently announcing that it is set to go public in a deal worth $2.8bn. This Premium Insight looks at how the vendor created this value, and what its next steps will be.

The insight is part of Signify Research’s Premium Insight – Medical Imaging subscription service.

To view the full insight on this development hit the Request Access button above for either a complimentary one month trial or to purchase a subscription.

The Signify Research’s Premium Insight – Medical Imaging subscription service provides:

  • Approximately 100 actionable and up to the moment Premium Insights per year.
  • A subscription to Signify Premium Insights – Medical Imaging provides compelling thought leadership on the most pertinent developments in healthcare technology.
  • This service utilises Signify Research’s expansive market data to properly appraise and interpret breaking news stories.
  • Major market moves and industry-changing announcements are evaluated as they unfold, and the considered opinions of Signify Research’s expert analysts are shared to provide insight into current developments.
  • Key vendors, technologies and conferences are followed, with updates carefully scrutinised to ensure that the most important details are revealed and properly assessed.